Leap Investments’s OptiNose OPTN Stock Holding History

Leap Investments’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-967	Closed	-$134K	–	513
2019 Q4	$134K	Buy	+967	New	+$125K	0.06%	361

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Leap Investments's OPTN Position: Q1 2020 in Review

Leap Investments sold out of OptiNose (OPTN) in Q1 2020, closing a stake of 967 shares — an estimated $134K sold.

Leap Investments first reported a position in OPTN in Q4 2019 and held it in 1 quarter. The position peaked at $134K in Q4 2019. 81 funds tracked by Wall St. Rank hold OPTN as of Q1 2020.

Leap Investments reported no remaining OptiNose position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 967 OptiNose shares in Q1 2020, an estimated $134K.
Leap Investments first reported a position in OptiNose in Q4 2019 and held it in 1 quarter.
Leap Investments's OptiNose position peaked at $134K in Q4 2019.
81 funds tracked by Wall St. Rank held OptiNose as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.